Twist Bioscience (TWST) Enterprise Value (2017 - 2025)
Historic Enterprise Value for Twist Bioscience (TWST) over the last 9 years, with Q4 2025 value amounting to -$198.0 million.
- Twist Bioscience's Enterprise Value rose 2689.06% to -$198.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$198.0 million, marking a year-over-year increase of 2689.06%. This contributed to the annual value of -$232.4 million for FY2025, which is 1590.64% up from last year.
- Twist Bioscience's Enterprise Value amounted to -$198.0 million in Q4 2025, which was up 2689.06% from -$232.4 million recorded in Q3 2025.
- In the past 5 years, Twist Bioscience's Enterprise Value ranged from a high of -$198.0 million in Q4 2025 and a low of -$573.9 million during Q1 2022
- Its 5-year average for Enterprise Value is -$368.0 million, with a median of -$323.8 million in 2023.
- Within the past 5 years, the most significant YoY rise in Twist Bioscience's Enterprise Value was 4860.09% (2021), while the steepest drop was 14152.32% (2021).
- Quarter analysis of 5 years shows Twist Bioscience's Enterprise Value stood at -$301.9 million in 2021, then plummeted by 45.34% to -$438.7 million in 2022, then grew by 29.08% to -$311.1 million in 2023, then increased by 12.96% to -$270.8 million in 2024, then rose by 26.89% to -$198.0 million in 2025.
- Its Enterprise Value was -$198.0 million in Q4 2025, compared to -$232.4 million in Q3 2025 and -$250.8 million in Q2 2025.